Large-scale testing (Phase 3)Active Not RecruitingNCT05985915
What this trial is testing
A Randomized, Double-blind 2-arm NEPTUNUS Extension Study to Assess the Long-term Safety and Efficacy of Ianalumab in Patients With Sjogrens Syndrome.
Who this might be right for
Sjogrens Syndrome
Novartis Pharmaceuticals 612